Azlocillin: Difference between revisions
m Drugbox, unknown parameters: fix sp, remove, rename (via AWB script) |
|||
Line 5: | Line 5: | ||
| IUPAC_name = (2''S'',5''R'',6''R'')-3,3-dimethyl-7-oxo-6-{[(2''R'')-2-{[(2-oxoimidazolidin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
| IUPAC_name = (2''S'',5''R'',6''R'')-3,3-dimethyl-7-oxo-6-{[(2''R'')-2-{[(2-oxoimidazolidin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
||
| image = Azlocillin skeletal.svg |
| image = Azlocillin skeletal.svg |
||
⚫ | |||
⚫ | |||
| tradename = |
| tradename = |
||
| Drugs.com = {{drugs.com|international|azlocillin}} |
| Drugs.com = {{drugs.com|international|azlocillin}} |
||
⚫ | |||
⚫ | |||
| CASNo_Ref = {{cascite|correct|CAS}} |
|||
| CAS_number_Ref = {{cascite|correct|??}} |
| CAS_number_Ref = {{cascite|correct|??}} |
||
| CAS_number = 37091-66-0 |
| CAS_number = 37091-66-0 |
||
Line 18: | Line 15: | ||
| PubChem = 6479523 |
| PubChem = 6479523 |
||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
| DrugBank = DB01061 |
|||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 4980416 |
| ChemSpiderID = 4980416 |
||
Line 29: | Line 26: | ||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
||
| ChEMBL = 1537 |
| ChEMBL = 1537 |
||
⚫ | |||
⚫ | |||
| C=20 | H=23 | N=5 | O=6 | S=1 |
| C=20 | H=23 | N=5 | O=6 | S=1 |
||
| molecular_weight = 461.491 g/mol |
| molecular_weight = 461.491 g/mol |
Revision as of 13:45, 20 November 2015
This article needs additional citations for verification. (August 2013) |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.048.483 |
Chemical and physical data | |
Formula | C20H23N5O6S |
Molar mass | 461.491 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Azlocillin is an acylampicillin antibiotic with an extended spectrum of activity and greater in vitro potency than the carboxy penicillins. Azlocillin is similar to mezlocillin and piperacillin. It demonstrates antibacterial activity against a broad spectrum of bacteria, including Pseudomonas aeruginosa and, in contrast to most cephalosporins, exhibits activity against enterococci.
Spectrum of bacterial susceptibility
Azlocillin is considered a broad spectrum antibiotic and can be used against a number of Gram positive and Gram negative bacteria. The following represents MIC susceptibility data for a few medically significant organisms.[1]
- Escherichia coli 1 μg/mL – 32 μg/mL
- Haemophilus spp. 0.03 μg/mL – 2 μg/mL
- Pseudomonas aeruginosa 4 μg/mL – 6.25 μg/mL
Synthesis
An interesting alternative synthesis of azlocillin involves activation of the substituted phenylglycine analogue 1 with 1,3-dimethyl-2-chloro-1-imidazolinium chloride (2) and then condensation with 6-APA.
See also
References
- ^ http://www.toku-e.com/Assets/MIC/Azlocillin%20sodium%20salt.pdf
- ^ a b H. B. Konig et al., Eur. J. Med. Chem. - Chim. Ther. 17, 59 (1982).
- ^ Bauer, Victor J.; Safir, S. R. (1966). "Octamethylbiguanide Perchlorate". Journal of Medicinal Chemistry. 9 (6): 980. doi:10.1021/jm00324a056. PMID 4291383.